MentionFox
Home › funding signals › Kaida BioPharma Inc.
Company · SEC filings

Kaida BioPharma Inc. funding history

Kaida BioPharma Inc. has 3 Form D filings on record, from 2023-06-14 to 2026-09-01. Together its new offerings report $1.57M sold.

Funding historyFounders and team

What do you want to do with Kaida BioPharma Inc.?

Based
FORT LAUDERDALE, FLORIDA
Year formed
2022
Industry group
Biotechnology
Filings
3
Raised (new offerings)
$1.57M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-09-01Amendment
first sale 2023-10-24
$1.60M$4.10MSEC filing
2026-01-21New offering
first sale 2023-10-24
$1.57M$3Mdetails · SEC filing
2023-06-14Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Kaida BioPharma Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/kaida-biopharma-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
Kaida BioPharma Inc. funding history: 3 SEC filings, $1.57M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/kaida-biopharma-inc